Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
hemangioma/tyrosine
リンクがクリップボードに保存されます
6 結果
Gene therapy for inhibition of angiogenesis
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
FIELD OF THE INVENTION
The present invention relates to methods of gene therapy for inhibiting angiogenesis associated with tumor growth, inflammation, psoriasis, rheumatoid arthritis, hemangiomas, diabetic retinopathy, angiofibromas, and macular degeneration.
This invention also relates to animal
Substituted phenylacrylonitrile compounds and compositions thereof for the treatment of disease
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
1. INTRODUCTION
The present invention relates to novel compounds capable of modulating and/or regulating tyrosine kinase signal transduction. The Applicants have demonstrated that the murine fetal liver kinase 1 (FLK-1) receptor and its non-murine counterparts, including the human Kinase
Compounds for the treament of disorders related to vasculogenesis and/or angiogenesis
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
1. INTRODUCTION
The present invention relates to novel compounds capable of modulating and/or regulating tyrosine kinase signal transduction. The Applicants have demonstrated that the murine fetal liver kinase 1 (FLK-1) receptor and its non-murine counterparts, including the human Kinase
Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
1. INTRODUCTION
The present invention relates to novel compounds capable of modulating and/or regulating tyrosine kinase signal transduction. The Applicants have demonstrated that the murine fetal liver kinase 1 (FLK-1) receptor and its non-murine counterparts, including the human Kinase
Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
1. Introduction
The present invention relates to novel compounds capable of modulating and/or regulating tyrosine kinase signal transduction. The Applicants have demonstrated that the murine fetal liver kinase 1 (FLK-1) receptor and its non-murine counterparts, including the human Kinase
Quinazoline compounds and compositions thereof for the treatment of disease
登録ユーザーのみが記事を翻訳できます
ログインサインアップ
1. INTRODUCTION
The present invention relates to novel compounds capable of modulating and/or regulating tyrosine kinase signal transduction. The Applicants have demonstrated that the murine fetal liver kinase 1 (FLK-1) receptor and its non-murine counterparts, including the human Kinase
科学に裏打ちされた最も完全な薬草データベース
- 55の言語で動作します
- 科学に裏打ちされたハーブ療法
- 画像によるハーブの認識
- インタラクティブGPSマップ-場所にハーブをタグ付け（近日公開）
- 検索に関連する科学出版物を読む
- それらの効果によって薬草を検索する
- あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください
症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています
